Joesting D R, Beart R W, van Heerden J A, Weiland L H
Am J Surg. 1981 Feb;141(2):228-31. doi: 10.1016/0002-9610(81)90163-x.
The records of 104 patients with primary adenocarcinoma of the duodenum were reviewed. All patients were followed up to the date of this report, 91 for at least 5 years. Melena was an ominous preoperative finding. Survival was directly related to nodal status, the grade of the lesion, and the ability of the surgeon to minimize or eliminate operative mortality. Fifty percent of the lesions were resectable for cure, and the 5 year survival rate for patients with resectable lesions was 46 percent. All eight patients treated with segmental resections for lesions in the third and fourth portions of the duodenum survived at least 5 years. These data are a great improvement over those in previous reports and suggest that this disease may be much more treatable than previously believed.
回顾了104例十二指肠原发性腺癌患者的记录。所有患者均随访至本报告日期，91例至少随访了5年。黑便是术前不祥的表现。生存率与淋巴结状态、病变分级以及外科医生将手术死亡率降至最低或消除手术死亡率的能力直接相关。50%的病变可切除以治愈，可切除病变患者的5年生存率为46%。所有8例因十二指肠第三和第四部分病变接受节段性切除治疗的患者均存活至少5年。这些数据比以前的报告有了很大改善，表明这种疾病可能比以前认为的更具可治性。
